Clinical Trials at Covance Clinical Research Unit AG
During the past decade, Covance Clinical Research Unit AG conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
A Re-licensing Study to Assess the Efficacy of Inflexal V Formulated With WHO Recommended 2008/2009 Influenza Virus Strains for the Northern Hemisphere
A Re-licensing Study to Assess the Efficacy of Inflexal V Formulated With WHO Recommended 2009/2010 Influenza Virus Strains for the Northern Hemisphere
A Re-licensing Study to Assess the Efficacy of Inflexal V Formulated With WHO Recommended 2010/2011 Influenza Virus Strains for the Northern Hemisphere
Immunogenicity and Safety Study to Assess Influenza Vaccine Formulated With Haemagglutinin (HA) Antigen From Two Different Suppliers
2011-10-01
2011-12-01
Completed
440
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Covance Clinical Research Unit AG"
#1 collaborator was "Shin Poong Pharmaceuticals" with 3 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Covance Clinical Research Unit AG
According to Clinical.Site data, the most researched conditions in "Covance Clinical Research Unit AG" are
"Influenza" (6 trials), "Malaria" (3 trials) and "Recurrent Vulvovaginal Candidiasis" (1 trials). Many other conditions were trialed in "Covance Clinical Research Unit AG" in a lesser frequency.
Clinical Trials Intervention Types at Covance Clinical Research Unit AG
Most popular intervention types in "Covance Clinical Research Unit AG" are "Biological" (7 trials) and "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Inflexal V" (4 trials), "14C-labeled Pyronaridine" (1 trials), "Inflexal V influenza vaccine (AdImmune HA antigen) 2010/2011" (1 trials), "Inflexal V influenza vaccine (CSL HA Antigen) 2010" (1 trials) and "Metoprolol and Pyronaridine : artesunate" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Covance Clinical Research Unit AG
The vast majority of trials in "Covance Clinical Research Unit AG" are
8 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Covance Clinical Research Unit AG
Currently, there are NaN active trials in "Covance Clinical Research Unit AG".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 10 completed trials in Covance Clinical Research Unit AG,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Covance Clinical Research Unit AG, 4 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 0 trials that are defined as “Not Applicable".